Press Room

News from The Max Foundation

First Doses of BRUKINSA® provided to Patients with Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries Under Collaboration of The Max Foundation, BeiGene, and the BeiGene Foundation

Armenia and Nepal are the first of 29 countries to receive BRUKINSA SEATTLE & BASEL & BEIJING & CAMBRIDGE, Mass. – March 13, 2024 — The Max Foundation (Max), a...

The Max Foundation Announces Agreement with Lilly to Provide Access to Verzenio® (abemaciclib) for the Treatment of Advanced Breast Cancer in Kenya

Agreement to provide Verzenio® (abemaciclib) free of charge to patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer (ABC) Lilly joins ongoing effort of...

lilly press release - doctor with a mask helping patient for max foundation eoy campaign

Targeted Treatment for Advanced Breast Cancer Including CDK4/6 Inhibitor Therapy Reaches Patients in Mozambique for the First Time

Three women diagnosed with HER2- HR+ advanced breast cancer in Mozambique have begun treatment, with efforts underway to open access in eight additional countries The Max Foundation leading initiative through...

Publications and Press

Cancer patients receive vital treatment from The Max Foundation | Seattle Refined

C-Sessions with Michael Wrigglesworth CTO of The Max Foundation | C-Sessions Podcast hosted by Randall Broad

Pat Garcia-Gonzalez and Dr. Jerry Radich on C-Sessions | C-Sessions Podcast hosted by Randall Broad

Media Contact

Please contact us with any requests or stories.

news@themaxfoundation.org